Koss-Olinger Consulting’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$210K Hold
6,524
0.02% 244
2025
Q4
$275K Sell
6,524
-4,891
-43% -$197K 0.02% 236
2025
Q3
$309K Hold
11,415
0.03% 262
2025
Q2
$309K Sell
11,415
-429
-4% -$12.4K 0.03% 265
2025
Q1
$351K Hold
11,844
0.03% 241
2024
Q4
$469K Hold
11,844
0.04% 133
2024
Q3
$403K Hold
11,844
0.04% 188
2024
Q2
$257K Buy
+11,844
New +$249K 0.02% 226
2024
Q1
Sell
-11,966
Closed -$329K 301
2023
Q4
$329K Buy
11,966
+8
+0.1% +$193 0.03% 228
2023
Q3
$267K Buy
11,958
+15
+0.1% +$386 0.04% 208
2023
Q2
$304K Hold
11,943
0.04% 183
2023
Q1
$266K Sell
11,943
-747
-6% -$18.1K 0.03% 190
2022
Q4
$301K Buy
+12,690
New +$295K 0.04% 159
2022
Q1
Sell
-7,567
Closed -$312K 234
2021
Q4
$312K Buy
+7,567
New +$334K 0.05% 151

Other funds holding VCYT

Koss-Olinger Consulting's VCYT Position: Q1 2026 in Review

Koss-Olinger Consulting held its Veracyte (VCYT) position steady in Q1 2026 at 6,524 shares worth $210K. The position accounts for 0.02% of the portfolio, ranked #244.

Koss-Olinger Consulting first reported a position in VCYT in Q4 2021 and has held it in 14 quarters since. The position peaked at $469K in Q4 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Koss-Olinger Consulting held 6,524 shares of Veracyte worth $210K as of Q1 2026.
  • Koss-Olinger Consulting left its Veracyte share count unchanged in Q1 2026.
  • Veracyte made up 0.02% of Koss-Olinger Consulting's portfolio in Q1 2026, its #244 holding.
  • Koss-Olinger Consulting first reported a position in Veracyte in Q4 2021 and has held it in 14 quarters since.
  • Koss-Olinger Consulting's Veracyte position peaked at $469K in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.